Clinical Benefits of 7 Years of Treatment with Omalizumab in Severe Uncontrolled Asthmatics

Author: Pace Elisabetta   Ferraro Maria   Bruno Andreina   Chiappara Giuseppina   Bousquet Jean   Gjomarkaj Mark  

Publisher: Informa Healthcare

ISSN: 0277-0903

Source: Journal of Asthma, Vol.48, Iss.4, 2011-05, pp. : 387-392

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract